The Discounted Cash Flow (DCF) valuation of Bolt Biotherapeutics Inc (BOLT) is (646.70) USD. With the latest stock price at 5.65 USD, the upside of Bolt Biotherapeutics Inc based on DCF is -11546.0%.
Based on the latest price of 5.65 USD and our DCF valuation, Bolt Biotherapeutics Inc (BOLT) is a sell. selling BOLT stocks now will result in a potential gain of 11546.0%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 4.7% - 6.1% | 5.4% |
| Long-term Growth Rate | 3.0% - 4.5% | 3.7% |
| Fair Price | (4,242.37) - (356.44) | (646.70) |
| Upside | -75186.3% - -6408.7% | -11546.0% |